PPTA Twitter

PlasmaProteins Cost-effectiveness assessments often don’t consider value from the perspective of individuals with chronic conditions. Learn more from experts with @PHEconomics here bit.ly/2rTWv64 pic.twitter.com/tlY0zh627h
2 days ago.
PlasmaProteins Every plasma donation is a gift for those with rare & serious conditions. Plasma is manufactured into life-saving #plasmaprotein therapies, that can help improve quality of life for those who rely on them. Learn more & find a center: bit.ly/2DFX3in #PlasmaDonorsSaveLives pic.twitter.com/2c9IIr0UJH
4 days ago.

Plasma Protein Therapeutics Association

The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions.

Erica XLA

PPTA works globally to:

    • Advocate for access to and affordability of therapies for patients
    • Engage in constructive dialogue with regulatory agencies
    • Collaborate with patient advocacy organizations

PPTA also administers standards and programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100